Showing results (31-40 of 53) with videos related to

Sort By:
Pageof 6
Cancer|January 10, 2001
Primary central nervous system lymphoma 1991-1997: outcome and late adverse effects after combined modality treatmentU Herrlinger, M Schabet, W Brugger, et al.
Oncology|February 17, 2009
Nimustine (ACNU) plus teniposide (VM26) in recurrent glioblastomaM Glas, T Hundsberger, M Stuplich, et al.
Acta Neurologica Scandinavica|May 12, 1998
Clinical presentation and therapeutic outcome in 26 patients with primary CNS lymphomaU Herrlinger, M Schabet, M Clemens, et al.
Human Gene Therapy|July 26, 2000
Helper virus-free herpes simplex virus type 1 amplicon vectors for granulocyte-macrophage colony-stimulating factor-enhanced vaccination therapy for experimental gliomaU Herrlinger, A Jacobs, A Quinones, et al.
The Journal of Gene Medicine|October 25, 2000
HSV-1 infected cell proteins influence tetracycline-regulated transgene expressionU Herrlinger, P A Pechan, A H Jacobs, et al.
Acta Neuropathologica|June 27, 2000
Central nervous system Hodgkin's lymphoma without systemic manifestation: case report and review of the literatureU Herrlinger, K Klingel, R Meyermann, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|August 10, 2000
Neural precursor cells for delivery of replication-conditional HSV-1 vectors to intracerebral gliomasU Herrlinger, C Woiciechowski, M Sena-Esteves, et al.
Cancer Gene Therapy|December 31, 1997
Vaccination for experimental gliomas using GM-CSF-transduced glioma cellsU Herrlinger, C M Kramm, K M Johnston, et al.
Human Gene Therapy|February 18, 1999
Intraarterial delivery of adenovirus vectors and liposome-DNA complexes to experimental brain neoplasmsN G Rainov, K Ikeda, N H Qureshi, et al.
Human Gene Therapy|October 20, 1996
Long-term survival in a rodent model of disseminated brain tumors by combined intrathecal delivery of herpes vectors and ganciclovir treatmentC M Kramm, N G Rainov, M Sena-Esteves, et al.
Pageof 6